FT
VERA icon

Fiduciary Trust’s Vera Therapeutics VERA Stock Holding History

Fiduciary Trust’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+5,259
New +$196K ﹤0.01% 844
2026
Q1 		– Sell
-4,902
Closed -$248K – 908
2025
Q4 		$248K Buy
+4,902
New +$174K ﹤0.01% 777

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fiduciary Trust's VERA Position: Q2 2026 in Review

Fiduciary Trust opened a new position in Vera Therapeutics (VERA) in Q2 2026: 5,259 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #844 among its holdings. This is a return to the name: Fiduciary Trust previously reported a position in VERA as recently as Q4 2025.

Fiduciary Trust first reported a position in VERA in Q4 2025 and has held it in 2 quarters since. The position peaked at $248K in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Fiduciary Trust held 5,259 shares of Vera Therapeutics worth $226K as of Q2 2026.
  • Vera Therapeutics was a new Fiduciary Trust position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #844 holding.
  • Fiduciary Trust first reported a position in Vera Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Fiduciary Trust's Vera Therapeutics position peaked at $248K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.